San Francisco Bay Area biotech stories.
Friday, May 4, 2012
Codexis pharma enzymes boost revenue
Federal approval to manufacture an ingredient used in a popular drug for diabetics means Codexis Inc. has another revenue source
. The company develops industrial enzymes for the production of pharmaceuticals, biofuels and biobased chemicals, and pharmaceuticals have become a major portion of the company’s revenue.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)